ATB-346

DB15377InvestigationalSmall molecule

ATB-346 is under investigation in clinical trial NCT03220633 (Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects).

Mechanism: Pharmacologically active on Prostaglandin G/H synthase 2 and Human Cyclooxygenases
Curator reviewed
Formula / weight: C₂₁H₁₉NO₃S · 365.45 g/mol (avg)
Code names: ATB-346

Resolves to

Compound

Structure

InChIKeyYCNMAPLPQYQJFC-UHFFFAOYSA-NSMILESCOC1=CC2=CC=C(C=C2C=C1)C(C)C(=O)OC1=CC=C(C=C1)C(N)=S

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with ATB-346, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.